JAYEX Technology Ltd (JTL)

Snapshot

JTL's Principal Activity is the development and provision of healthcare industry service technologies and the development of integrated dispensing automation systems for the pharmaceutical and healthcare sectors.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
No dividends paid.

Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Name	Title	Since	Bio
Mr Nicholas Harper	Non-Executive Director	Sep 2020	Mr Nicholas Harper Non-Executive Director Mr Harper has over thirty years experience working in software development. During that time, he has worked in the public sector (local government), investment banking and the aviation sector in a range of roles and with responsibilities. Nick has worked on implementing and maintaining range of software systems from batch valuation systems to real-time data processing. He also has experience of project management and software team building.
Mr Michael Denis Boyd	Executive Chairman,Executive Director	May 2017	Mr Michael Denis Boyd Executive Chairman,Executive Director Mr Boyd has been involved in the creation of enterprises, both in the private and public sectors, for over 27 years. Mr Boyd has been in developing and growing new projects in areas including healthcare, telecommunications and finance. After leaving Sonic he started Foundation Healthcare, growing it to over 800 healthcare professionals before it was acquired by Sonic. He was also a founding partner of Iridium Satellite bringing it out from bankruptcy to now a listed company.
Mr Michael Chan	Non-Executive Director	Mar 2017	Mr Michael Chan Non-Executive Director Mr Chan has experience in based financial services for the past 30 years with hands on knowledge in both consumer and commercial segments. He is the founder and Managing Director at AMG Corporate Pty Ltd, a holder of an Australian Credit Licence which is primarily a debt advisory business. Prior to establishing AMG, he worked in key roles involved with business development and marketing at range of companies, both in the private and public sectors. He has had a past affiliation with Make a Wish Foundation and more recently is the founder and chairman of The Mate Foundation - a men's health initiative with its principal purpose to help raise awareness of men's health diseases, which is due to launch shortly. He has over the years also undertaken work for range of other charities and causes in his community. He is a member of the Risk Committee.
Ms Melanie Jaye Leydin	Company Secretary	Aug 2015
Mr Brian Renwick	Non-Executive Director	Jul 2009	Mr Brian Renwick Non-Executive Director Mr Renwick is experienced across the pharmaceutical and healthcare sector in Australia. His involvement with sector commenced in finance roles that led into commercial analysis, marketing and sales. From this commercial experience in the manufacturing end of the supply chain he moved into the wholesaling segment with various business development roles in retail and hospital pharmacy. Mr Renwick's roles has into commercial and business development including as general manager for a corporate pharmacy business. He has completed two Business Development roles within the CSL Limited group. With his detailed commercial knowledge and experience across the healthcare segment, Brian has provided consulting advice to Jayex since 2006 and is an important member of the team. He is a Chairman of the Risk Committee.
Nathan Woodard	Chief Financial Officer	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
22/09/21	Michael Chan	Issued	624,545	$0.025	$15,613	Rights issue
22/09/21	Michael Boyd	Issued	26,970,970	$0.025	$674,274	Rights issue
22/09/21	Brian Renwick	Issued	415,218	$0.025	$10,380	Rights issue
30/06/21	Michael Chan	Buy	+20,000	$0.027	$539	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Michael Chan	22/09/2021	0	2,498,180	N/A	N/A
Brian Renwick	22/09/2021	1,660,871	N/A	N/A	N/A
Michael Boyd	22/09/2021	N/A	107,883,880	N/A	N/A
Nicholas Harper	02/09/2020	0	N/A	N/A	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
Covenant Holdings(Wa)Pty Ltd <Boyd#4 A/C>	77,912,910	38.69%
Vector London Ltd	19,003,378	9.44%
Mr John Clive Allinson	6,120,000	3.04%
Altor Capital Management Pty Ltd <Altor Alpha Fund A/C>	5,092,000	2.53%
Mr Dean Henry Cleary <The Clearway Investment A/C>	4,140,000	2.06%
Bodie Investments Pty Ltd	3,074,304	1.53%
Donovan Products Pty Ltd <Family Account>	2,746,916	1.36%
Mr Mun Kee Chang	2,651,433	1.32%
Ms Chunyan Niu	2,000,000	0.99%
Mr Bilal Ahmad	2,000,000	0.99%
Amg Corporate Pty Ltd <The Amg Super Fund A/C>	1,853,635	0.92%
R & F Mantel Pty Ltd <R & F Mantel Super Fund A/C>	1,700,000	0.84%
Mr Peter Howells	1,558,243	0.77%
Covenant Holdings (Wa) Pty Ltd <The Boyd No 3 A/C>	1,500,000	0.74%
Covenant Holdings(Wa) Pty Ltd <Boyd Number 3 A/C>	1,500,000	0.74%
Ms Mandy Jean Rutherford	1,408,000	0.70%
A & D Holdings 2 Pty Ltd <A & D Hill Superfund A/C>	1,306,087	0.65%
Miss Olga Osipova	1,297,946	0.64%
Dennis Joseph Mcmahon	1,250,000	0.62%
Wayne Edward Beilby	1,250,000	0.62%
Mr Brian Patrick Renwick	1,227,840	0.61%
International Business Network (Services) Pty Ltd	1,200,000	0.60%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
No Financial Year End data available

JTL Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.